Moderna shares fall 18% after revised guidance shows $1B shortfallJanuary 13, 2025 Moderna Inc. experienced a sharp 18% drop in stock value on Monday after the company significantly reduced its 2025 revenue forecast by $1 billion. The biotech firm now projects revenue between $1.5 billion and $2.5 billion for 2025, a decline
